Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

EW · Edwards Lifesciences Corporation

$90.56 +1.67% Oct 26 close
Detected setup Falling Wedge · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about EW

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$EW

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $52B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 1
$90.56 latest close
Market Structure
Trend structure: range
Latest event: structure_shift (bullish)
Support 88.79–89.70 · 8 touches · strong
Support 86.98–87.44 · 6 touches · strong
Support 80.24–80.65 · 5 touches · strong
Support 83.60–83.81 · 4 touches · moderate
Support 84.49–85.06 · 4 touches · moderate
Verdict · setup score 55/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$85.00$90.00$95.00AugSepOct$90.56

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.8 RS rank ≥ 70 (prefer ≥ 85) — RS rank 61
  • Minervini 2. Quarterly EPS growth ≥ 25% — -26.1% QoQ
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -26.1% QoQ
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 61
  • Weinstein Volume expansion above average — Volume ratio 1.01x
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
Minority view — the council disagrees here
  • Minervini: watch Trend-template read: 7/13 pass; wait for the soft misses to improve.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
57 Neutral
Legend Score · rates the stock Neutral (57/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 61
  • Trend Template (25%) 75
  • Institutional Footprint (20%) 60
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 61: above-average strength. Trend template 6/8: passes the uptrend screen, structure intact. Institutional score 60: neutral — no clear institutional conviction. EPS -0% last quarter — no earnings momentum. Quality 44: weak fundamentals (sales growth 30, return on equity 40, leverage 100). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Wednesday, October 28, 2026 After market close Exact clock time not supplied by source

Deterministic evidence

EW+1.67%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. EW was +1.67 points vs XLV. +0.96 points vs SPY.
CatalystPending Stock reactionPositive Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+1.67% From the open+1.67% Range position92% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Short-term conviction -1 points.
  • A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $90.56 +1.7% Oct 26 close
52W High $96.29 6.0% below high
Wks Since High 15w
Base Depth 15.7%
RS Rank 22 percentile of scan
SMA 50 $88.04
Avg Vol 3,298,231
Rel Vol (Oct 26) 1.01× 1.05× on up days
More stats
52W Low $74.66
Tight Wks 1
Base B1
SMA 200 $85.26
RS Line vs High -8.9%
RS Line Slope +2.7% ▲
Group Rank #21/66
ADR% 2.4%
ATR(14) $2.02 (2.2%)
Vol Pace (live) N/A
A/D Days 22A / 13D
A/D Rating A+
VDU Bars 0/10 d
Earnings tomorrow
Position in 52-week range 74thpercentile of the 52-week range
$74.66low
$96.29high

EW Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for EW.

Create Free Account

Technical Analysis Report Card

$EW · $90.56 · as of 2026-10-26 · multi-factor read
80
/ 100
Technicals 80/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▲ Uptrend

Moving Averages

50-day$88.04 ↑
100-day$88.31 ↑
200-day$85.26 ↑
Bullish (50 > 200)

RSI (14)

Reading60.3 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+0.545

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width102% · 7.9%

Riding the upper band — strong momentum, but stretched.

Volume · Buyer vs Seller

Up/Down vol1.05 · Neutral
Rel volume1.01×
Pocket pivots · 10d0
5d vs 50d vol84%
Heavy vol up / down0 / 1

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

  • 1 heavy-volume down day vs 0 up in the last 20 sessions — supply is showing.

Support & Resistance

R · $93.43swing level
R · $96.2952-week high
Price · $90.56now
S · $88.79swing level
S · $83.81swing level
S · $82.80swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$91.62
38.2%$88.73
50.0%$86.39
61.8%$84.05
78.6%$80.73

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for EW — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Monthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about EW
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (55/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Watch D Trend-template read: 7/13 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $90.56, MA150 $86.22, MA200 $85.26
1.2 150-day MA > 200-day MAMA150 $86.22 vs MA200 $85.26
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 61
2. Quarterly EPS growth ≥ 25%-26.1% QoQ
7/13 checks
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

partialRule check says AVOID (2/8 checks passed) — CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high6.0% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.23%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-26.1% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 61
2/8 checks
Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $90.56 vs MA200 $85.26
Failing evidence
Volume expansion above averageVolume ratio 1.01x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $82.43
Volatility-unit sizing (1N ≈ 1% of equity)1N = $2.05 (2.26% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/8 checks
zanger Avoid D Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $104.14-$108.67; trail the rest
Trail on the 10/20-day MA10-day MA $88.00 · 20-day MA $87.01 — exit the remainder on a close below the trail
Failing evidence
Named Zanger pattern onlyFalling Wedge is not one of Zanger's six
Not extended (≤5% above the breakout point)Not confirmed
3/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Reasonable price for the growth (P/E ≤ 35); Insider buying; Price strength (RS ≥ 70) — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (2025 adv / 1725 dec) — participation expanding
4% Model (breadth proxy)63% of universe above 50-day — broad strength (adapted from Ned Davis 4% Model)
Failing evidence
EPS growth above the market (≥15% QoQ)-26.1% QoQ — Zweig wants growth above the S&P average
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 49.5x — no PEG or forward P/E stored
2/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$90.56
Distance from 52-week high6.0% below high
Failing evidence
Relative strengthRS 61
Volume vs average1.01x
3/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but relative strength is unresolved.

mediumBuilding the top of the box (6.0% from 52W high) — watch for a box breakout with volume expansion.

Passing evidence
Price$90.56
Distance from 52-week high6.0% below high
Failing evidence
Relative strengthRS 61
Volume vs average1.01x
3/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$90.56
Distance from 52-week high6.0% below high
Failing evidence
Relative strengthRS 61
Volume vs average1.01x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Bullish Engulfing — Today's up candle fully engulfs yesterday's down candle — a classic bullish reversal, strongest after a pullback to support.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
100RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +0 A+
A: 14 D: 14 Net: +065 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -26%
✗ Revenue growth ≥20% YoY +12%
✓ Gross margin ≥30% 78%
✗ ROE ≥17% 11%
✗ RS rating ≥80 (leadership) 61
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -6.0%

Method Playbook

Trade it like Zanger EXACT LEVELS · PRO
Zanger D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the breakout point of a named pattern (flat base, bull flag, ascending triangle, cup and handle, double bottom, symmetrical triangle).
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Buy the breakout day on 150-200% of average volume. Never pay more than 5% above the breakout point.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Set the stop 2-3% below entry and sell on bad price action before it is even hit.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Sell 20-30% of the position at +15-20% from the breakout, then trail the rest on the 10/20-day moving average.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Out on a break of the 10/20-day MA, a failed breakout back below the pivot, or a reversal pattern — winners are held, laggards are sold fast.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Forming Patterns (predictive — not confirmed)

Head & Shoulders bearish forming
75% built

Possible head & shoulders top — not confirmed. Watch for a daily close below ~70.03 (neckline) to confirm, with measured-move risk toward ~43.77. A push back above 93.91 weakens the pattern; reclaiming 96.29 invalidates it.

Confirms below 70.03
Invalidates at 96.29
Left Shoulder 89.60
Head 96.29
Right Shoulder 93.91
Neckline 70.03
Target 43.77

LS 89.60 / head 96.29 / RS 93.91, neckline ~70.03, vol_fading=no

Cup & Handle bullish early
60% built

Cup base building — 62% of the 16%-deep cup recovered. Watch for the right side to reach ~96.29, then a handle.

Confirms above 96.29
Invalidates at 88.72
Rim 96.29
Cup Low 81.15
Pivot 96.29
Mid Cup 88.72

Cup depth 16%, recovery 62%, handle=not yet

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

Falling Wedge ⚠ Extended past buy zone ⚠ Not actionable yet
55 setup score
RS Score 61
Trend template 6/8
CANSLIM 60.5* (C)
upper slope: -0.206 lower slope: -0.0464 depth: 0.024 narrowing ratio: 0.139 prior decline: 0.157 upper touches: 3 lower touches: 3 vol declining: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 6/8 confirmed
Why This Setup? D+W Confluence
Falling Wedge · schematic

prior_decline=15.7%, converging=yes, narrowing=14%, touches=upper:3/lower:3, near_upper=yes | Moderate trend (6/8) | Good RS (61) | High-confidence pattern (85%) | Stage 2 | Candle confirmation (bullish) | Readiness 47/100 (early) | CANSLIM 60.5 (C) | ⚠ Extended past buy zone; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

3/7 universals met
  • A relative-strength leader — not met RS rank 22 — laggard
  • Clear of earnings — not met in 1 days — event risk
  • Not chasing (in range) — partly met Partly met — levels are a Pro detail
  • Volume confirms — partly met 1.0× average — light
  • Asymmetric reward — met Met — levels are a Pro detail
  • In a confirmed uptrend — met Stage 2 · Trend template 6/8
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $90.56 vs SMA150 $86.22 / SMA200 $85.26
SMA 150 above SMA 200 SMA150 $86.22 vs SMA200 $85.26
SMA 200 trending up Slope +0.18 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $88.04
Price above SMA 50 $90.56 vs SMA50 $88.04
30%+ above 52-week low +21.3% from $74.66
Within 25% of 52-week high -6.0% from $96.29
RS score above 70 RS 61

Fundamentals

52W Range
74%
Mkt Cap SEC
52.2B
EPS QoQ
-26%
Rev YoY
+12%
ROE
11%
Gross Margin
78%
D/E
0.06
EPS TTM
$1.83
P/E TTM
49.5x
Float
576M
Insider
No Buy

Company

Company profile
Edwards Lifesciences Corporation
EW · NYSE · Health Technology · Medical Specialties
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C 60.5* CANSLIM * disqualified on C, M
C · Curr. EPS
20
A · Annual EPS
69
N · New Highs
100
S · Supply/Demand
80
L · Leader RS
61
I · Inst. Spons.
96
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
6/8
W. RS
59
W. Support
$76.49
W. Resist
$96.29
W. Patterns
Cup & Handle Basing
Weekly Structure

Scan History

20× streak
Oct 23: 55 (Falling Wedge)Oct 23: 77 (Falling Wedge)Oct 26: 55 (Falling Wedge)Oct 27: 55 (Falling Wedge)55
Oct 27
Falling Wedge ✓ Gate
55
Oct 26
Falling Wedge ✓ Gate
55 0.0%
Oct 23
Falling Wedge ✓ Gate
77 +1.7%
Oct 23
Falling Wedge ✓ Gate
55 +1.7%

Latest News

Headlines for EW
Loading headlines…

Get the full picture on EW

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial